Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
2002 1
2003 1
2004 2
2005 1
2006 1
2007 1
2008 3
2009 4
2010 3
2012 2
2014 1
2015 4
2016 2
2017 2
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
High Prevalence of Sarcopenia in HIV-Infected Individuals.
Echeverría P, Bonjoch A, Puig J, Estany C, Ornelas A, Clotet B, Negredo E. Echeverría P, et al. Among authors: Estany C. Biomed Res Int. 2018 Jul 12;2018:5074923. doi: 10.1155/2018/5074923. eCollection 2018. Biomed Res Int. 2018. PMID: 30112397 Free PMC article.
Gut Microbiota Linked to Sexual Preference and HIV Infection.
Noguera-Julian M, Rocafort M, Guillén Y, Rivera J, Casadellà M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, Rodríguez C, Carrillo J, Mothe B, Coll J, Bravo I, Estany C, Herrero C, Saz J, Sirera G, Torrela A, Navarro J, Crespo M, Brander C, Negredo E, Blanco J, Guarner F, Calle ML, Bork P, Sönnerborg A, Clotet B, Paredes R. Noguera-Julian M, et al. Among authors: Estany C. EBioMedicine. 2016 Jan 28;5:135-46. doi: 10.1016/j.ebiom.2016.01.032. eCollection 2016 Mar. EBioMedicine. 2016. PMID: 27077120 Free PMC article.
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection.
Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Guillén Y, et al. Among authors: Estany C. Mucosal Immunol. 2019 Jan;12(1):232-246. doi: 10.1038/s41385-018-0083-7. Epub 2018 Aug 31. Mucosal Immunol. 2019. PMID: 30171206
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
Negredo E, Langohr K, Bonjoch A, Pérez-Alvárez N, Estany C, Puig J, Rosales J, Echeverría P, Clotet B, Gómez G. Negredo E, et al. Among authors: Estany C. J Antimicrob Chemother. 2018 Sep 1;73(9):2452-2459. doi: 10.1093/jac/dky201. J Antimicrob Chemother. 2018. PMID: 29860519 Clinical Trial.
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.
Santos JR, Saumoy M, Curran A, Bravo I, Llibre JM, Navarro J, Estany C, Podzamczer D, Ribera E, Negredo E, Clotet B, Paredes R; Tenofovir/emtricitabine inflUence on LIPid metabolism (TULIP) Study Group. Santos JR, et al. Among authors: Estany C. Clin Infect Dis. 2015 Aug 1;61(3):403-8. doi: 10.1093/cid/civ296. Epub 2015 Apr 13. Clin Infect Dis. 2015. PMID: 25870325 Clinical Trial.
Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.
Negredo E, Estrada V, Domingo P, Gutiérrez MD, Mateo GM, Puig J, Bonjoch A, Ornelas A, Echeverría P, Estany C, Toro J, Clotet B. Negredo E, et al. Among authors: Estany C. J Antimicrob Chemother. 2017 Mar 1;72(3):844-849. doi: 10.1093/jac/dkw504. J Antimicrob Chemother. 2017. PMID: 27999056 Clinical Trial.
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.
Magnano L, Montoto S, González-Barca E, Briones J, Sancho JM, Muntañola A, Salar A, Besalduch J, Escoda L, Moreno C, Domingo-Domenech E, Estany C, Oriol A, Altés A, Pedro C, Gardella S, Asensio A, Vivancos P, Fernández de Sevilla A, Ribera JM, Colomer D, Campo E, López-Guillermo A. Magnano L, et al. Among authors: Estany C. Ann Hematol. 2017 Apr;96(4):639-646. doi: 10.1007/s00277-017-2920-2. Epub 2017 Jan 18. Ann Hematol. 2017. PMID: 28101592 Clinical Trial.
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.
Santos JR, Saumoy M, Curran A, Bravo I, Navarro J, Estany C, Podzamczer D, Ribera E, Negredo E, Clotet B, Paredes R. Santos JR, et al. Among authors: Estany C. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19550. doi: 10.7448/IAS.17.4.19550. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394057 Free PMC article.
34 results
Jump to page
Feedback